Chromobacterium sp. septicemia in Sweden. A clinical case report

IF 4.6 2区医学 Q1 MICROBIOLOGY

Annals of Clinical Microbiology and Antimicrobials Pub Date : 2024-04-18 DOI:10.1186/s12941-024-00692-5

Oscar Backrud, Erik Engberg, Kristina Nyberg, Peter Wieslander, Edward R. B. Moore

引用次数: 0

Abstract

Chromobacterium is a genus of fourteen species with validly published names, most often found in soil and waters in tropical and subtropical regions around the world. The most well-known species of the genus, C. violaceum, occasionally causes clinically relevant infections; cases of soft tissue infections with septicemia and fatal outcomes have been described. Here, we present a clinical case report of a 79-year-old man from Sweden with a soft-tissue infection and septicemia. The pathogen was identified as a strain of Chromobacterium species, but not C. violaceum. The patient was treated with clindamycin and ciprofloxacin and recovered well. This case report demonstrates the potential of Chromobacterium species as infectious agents in immunocompetent patients. It also indicates the existence of a novel species.

查看原文本刊更多论文

瑞典的铬杆菌败血症。临床病例报告

Chromobacterium 属有 14 个已公布有效名称的物种，最常见于世界各地热带和亚热带地区的土壤和水域中。该属中最著名的一种--C. violaceum--偶尔会引起临床相关感染；曾有软组织感染并导致败血症和致命后果的病例。在此，我们提供了一份来自瑞典的 79 岁男性软组织感染和败血症临床病例报告。经鉴定，病原体是一种色杆菌属菌株，而非暴发性色杆菌。患者接受克林霉素和环丙沙星治疗后恢复良好。该病例报告表明，色杆菌有可能成为免疫功能正常患者的传染源。它还表明了一种新型菌种的存在。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Annals of Clinical Microbiology and Antimicrobials MICROBIOLOGY-

CiteScore

8.60

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： Annals of Clinical Microbiology and Antimicrobials considers good quality, novel and international research of more than regional relevance. Research must include epidemiological and/or clinical information about isolates, and the journal covers the clinical microbiology of bacteria, viruses and fungi, as well as antimicrobial treatment of infectious diseases. Annals of Clinical Microbiology and Antimicrobials is an open access, peer-reviewed journal focusing on information concerning clinical microbiology, infectious diseases and antimicrobials. The management of infectious disease is dependent on correct diagnosis and appropriate antimicrobial treatment, and with this in mind, the journal aims to improve the communication between laboratory and clinical science in the field of clinical microbiology and antimicrobial treatment. Furthermore, the journal has no restrictions on space or access; this ensures that the journal can reach the widest possible audience.